374 related articles for article (PubMed ID: 19479962)
21. Histological characterization of retinal degeneration in mucopolysaccharidosis type IIIC.
Ludwig J; Sawant OB; Wood J; Singamsetty S; Pan X; Bonilha VL; Rao S; Pshezhetsky AV
Exp Eye Res; 2023 Apr; 229():109433. PubMed ID: 36858249
[TBL] [Abstract][Full Text] [Related]
22. Structure of the human heparan-α-glucosaminide
Navratna V; Kumar A; Rana JK; Mosalaganti S
bioRxiv; 2024 Jun; ():. PubMed ID: 37961489
[TBL] [Abstract][Full Text] [Related]
23. Drosophila melanogaster models of MPS IIIC (Hgsnat-deficiency) highlight the role of glia in disease presentation.
Hewson L; Choo A; Webber DL; Trim PJ; Snel MF; Fedele AO; Hopwood JJ; Hemsley KM; O'Keefe LV
J Inherit Metab Dis; 2024 Mar; 47(2):340-354. PubMed ID: 38238109
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B.
Aronovich EL; Johnston JM; Wang P; Giger U; Whitley CB
Genomics; 2001 Jun; 74(3):299-305. PubMed ID: 11414757
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles.
Canals I; Elalaoui SC; Pineda M; Delgadillo V; Szlago M; Jaouad IC; Sefiani A; Chabás A; Coll MJ; Grinberg D; Vilageliu L
Clin Genet; 2011 Oct; 80(4):367-74. PubMed ID: 20825431
[TBL] [Abstract][Full Text] [Related]
26. Lysosomal storage of heparan sulfate causes mitochondrial defects, altered autophagy, and neuronal death in the mouse model of mucopolysaccharidosis III type C.
Pshezhetsky AV
Autophagy; 2016 Jun; 12(6):1059-60. PubMed ID: 25998837
[TBL] [Abstract][Full Text] [Related]
27. Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.
Emre S; Terzioglu M; Tokatli A; Coskun T; Ozalp I; Weber B; Hopwood JJ
Hum Mutat; 2002 Feb; 19(2):184-5. PubMed ID: 11793481
[TBL] [Abstract][Full Text] [Related]
28. Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT.
Pan X; Taherzadeh M; Bose P; Heon-Roberts R; Nguyen ALA; Xu T; Pará C; Yamanaka Y; Priestman DA; Platt FM; Khan S; Fnu N; Tomatsu S; Morales CR; Pshezhetsky AV
J Exp Med; 2022 Aug; 219(8):. PubMed ID: 35704026
[TBL] [Abstract][Full Text] [Related]
29. Novel Direct Assay for Acetyl-CoA:α-Glucosaminide N-Acetyltransferase Using BODIPY-Glucosamine as a Substrate.
Choi Y; Tuzikov AB; Ovchinnikova TV; Bovin NV; Pshezhetsky AV
JIMD Rep; 2015 Oct; 28():11-8. PubMed ID: 26493749
[TBL] [Abstract][Full Text] [Related]
30. Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A).
Bunge S; Ince H; Steglich C; Kleijer WJ; Beck M; Zaremba J; van Diggelen OP; Weber B; Hopwood JJ; Gal A
Hum Mutat; 1997; 10(6):479-85. PubMed ID: 9401012
[TBL] [Abstract][Full Text] [Related]
31. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
Perkins KJ; Muller V; Weber B; Hopwood JJ
Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
[TBL] [Abstract][Full Text] [Related]
32. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A).
Tomatsu S; Montaño AM; Nishioka T; Gutierrez MA; Peña OM; Tranda Firescu GG; Lopez P; Yamaguchi S; Noguchi A; Orii T
Hum Mutat; 2005 Dec; 26(6):500-12. PubMed ID: 16287098
[TBL] [Abstract][Full Text] [Related]
33. Sanfilippo syndrome type C: deficiency of acetyl-CoA:alpha-glucosaminide N-acetyltransferase in skin fibroblasts.
Klein U; Kresse H; von Figura K
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5185-9. PubMed ID: 33384
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of Portuguese patients with mucopolysaccharidosis IIIC: two novel mutations in the HGSNAT gene.
Coutinho MF; Lacerda L; Prata MJ; Ribeiro H; Lopes L; Ferreira C; Alves S
Clin Genet; 2008 Aug; 74(2):194-5. PubMed ID: 18518886
[No Abstract] [Full Text] [Related]
35. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
36. Mouse model of Sanfilippo syndrome type B: relation of phenotypic features to background strain.
Gografe SI; Garbuzova-Davis S; Willing AE; Haas K; Chamizo W; Sanberg PR
Comp Med; 2003 Dec; 53(6):622-32. PubMed ID: 14727810
[TBL] [Abstract][Full Text] [Related]
37. Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase.
Litjens T; Hopwood JJ
Hum Mutat; 2001 Oct; 18(4):282-95. PubMed ID: 11668612
[TBL] [Abstract][Full Text] [Related]
38. Sanfilippo type C diagnosis: assay of acetyl-CoA: alpha-glucosaminide N-acetyltransferase using [14C]glucosamine as substrate and leukocytes as enzyme source.
Pallini R; Leder IG; di Natale P
Pediatr Res; 1984 Jun; 18(6):543-5. PubMed ID: 6429622
[TBL] [Abstract][Full Text] [Related]
39. Glycosaminoglycans and mucopolysaccharidosis type III.
Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G
Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513
[TBL] [Abstract][Full Text] [Related]
40. Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC.
Marcó S; Pujol A; Roca C; Motas S; Ribera A; Garcia M; Molas M; Villacampa P; Melia CS; Sánchez V; Sánchez X; Bertolin J; Ruberte J; Haurigot V; Bosch F
Dis Model Mech; 2016 Sep; 9(9):999-1013. PubMed ID: 27491071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
